Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Humanin rescues neuronal cells from FAD gene- and Abeta-induced death

June 11, 2001

New studies suggest long-term efficacy and safety, dose-related response for modafinil

June 11, 2001

Cannabinoids a focus of research at U. of Connecticut

June 8, 2001

FDA advisory committee votes in favor of Xyrem's efficacy for cataplexy

June 8, 2001

Prostanoid EP1 antagonist ZD-6416 as a novel therapy for common painful disorder

June 8, 2001

Zomig-ZMT now available in U.S. for treatment of migraine

June 8, 2001

GlaxoSmithKline portfolio includes newly patented 5-HT7 antagonists

June 7, 2001

Antiapoptotic compounds from ARS act on Bax and cytochrome c

June 6, 2001

Bicyclic amino acids mimic effects of gabapentin, may be useful for neuropathological conditions

June 6, 2001

Lilly's Zyprexa approved for treatment of schizophrenia in Japan

June 6, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...